3-epicabraleabydroxylactone and other triterpenoids from camellia oil and their inhibitory effects on Epstein-Barr virus activation
3-epicabraleabydroxylactone and other triterpenoids from camellia oil and their inhibitory effects on Epstein-Barr virus activation
复制标题
DOI:
10.1248/cpb.52.153
复制
发表时间:
2004-01-01
影响因子:
1.7
通讯作者:
Nishino, H
中科院分区:
文献类型:
--
作者:
Akihisa, T;Tokuda, H;Nishino, H
The structure of a triterpenoid isolated from the nonsaponifiable lipid (NSL) of the seed oil of the camellia (Camellia japonica L.; Theaccae) was established to be (20S)-3beta-hydroxy-25,26,27-trisnordammaran-24,20-olide (1; 3-epicabraleahydroxylactone) on the basis of spectroscopic and chemical methods. Six other triterpenoids isolated from the NSL were identified as 3-epicabraleadiol (2), ocotillol II (3), ocotillol I (4), dammarenediol II (5), (20R)-taraxastane-3beta,20-diol (6), and lupane-3beta,20-diol (7). Upon evaluation of the seven triterpenoids (1-7) with respect to their inhibitory effects on the induction of Epstein-Barr virus early antigen (EBV-EA) by 12-O-tetradecanoviphorbol-13-acetate (TPA) in Raji cells, three compounds (5-7) showed potent inhibitory effects against EBV-EA induction (IC50 values of 277-420 mol ratio/32 pmol TPA).